ACE and chronic kidney disease: QIACEi+ARB: proportion of patients ≥70 years with CKD who had multiple (≥2) dual prescriptions of ACE inhibitors and ARBs over at least two quarters within three quarters after the quarter with the first simultaneous prescription (non-recommended)